Webinars
In these online education webinars, leading experts address current treatments and controversies in various urological subspecialties.
International key opinion leaders explain the latest urological developments in a concise presentation and give ample opportunities to interact and pose questions. All webinars will be recorded and can be reviewed at a later stage. Both advanced urologists as urologists in training can enjoy the webinars for free via desktop, tablet or mobile phone, anytime, anywhere.
Keep me posted
Stay informed about upcoming UROwebinars. Update or create your MyEAU account and select your fields of interest.
Go to MyEAUUROTech Forum - REZUM - Boston Scientific
Technology Forum
Join Prof Richard Hindley who will share his personal experiences with Rezum™ Water Vapour Therapy; from his clinical practice to latest advancements.
REZUM,™ Water Vapour Therapy provides durable significant improvement for BPH patients with a prostate volume between 30-80cc.1
1 McVary KT, Roehrborn C. Five year results of the prospective, randomized controlled trial of water vapor thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Late-Breaking Abstract. J Urol. 2020 Apr;203(4):e1021.
30 September
18.30 – 19.30 CEST
Moderator:
Prof. T. Bach, Hamburg (DE)
Presenter:
Prof. R. Hindley, London (UK)
Counterpart:
Prof. T. Knoll, Sindelfingen (DE)
Boston Scientific - REZUM
UROwebinar: Advanced course on the laparoscopic management of the renal and ureteropelvic junction disease
In recent years technological advances raised not only in robotic surgery but also in laparoscopy. New vision systems improved significantly the quality of our laparoscopic procedures, extending indication to complex pathologies. Moreover, many ancillary technologies focused on image guidance have been developed to maximize surgical outcomes. With this advanced course we aim to give the attendees an overview of these recent innovations and surgical advances for the laparoscopic management of renal and ureteropelvic junction diseases, considering complex or locally-advanced renal tumors as well as challenging UPJ obstructions. We are confident to comply the participants expectations.